CALLAHAN ADVISORS, LLC – Bristol-Myers Squibb Company Transaction History
CALLAHAN ADVISORS, LLC portfolio value:
$6.87M
portfolio value
CALLAHAN ADVISORS, LLC quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +12.54% | 10.78K shares | 258K | $71.09 | 96.74K |
| Q2 2022 | share | Increase | +3.96% | 3.27K shares | 581K | $77 | 85.95K |
| Q1 2022 | share | Increase | +5.49% | 4.30K shares | 1.15M | $73.03 | 82.68K |
| Q4 2021 | share | Decrease | -27.56% | -29.81K shares | -1.51M | $62.52 | 78.37K |
| Q3 2021 | share | Increase | +4.77% | 4.92K shares | -499K | $59.17 | 108.19K |
| Q2 2021 | share | Increase | +13.86% | 12.57K shares | 1.17M | $65.79 | 103.27K |
| Q1 2021 | share | Increase | +31.44% | 21.69K shares | 1.44M | $62.15 | 90.69K |
| Q4 2020 | share | Increase | +108.20% | 35.85K shares | 2.28M | $60.6 | 69K |
| Q3 2020 | share | Increase | 0.00% | 33.14K shares | 1.99M | $58 | 33.14K |